22MA032N Detection: Utilization Of Immortalized B Cells to Identify Sdcbp as a Novel Therapeutic Target in Ovarian Carcinoma
FOR MORE INFORMATION ON THIS TECHNOLOGY, PLEASE CONTACT OUR OFFICE
The Innovation Office
InnovationMarketing@Moffitt.org
(813) 745-6828